Br J Dermatol. 2004 Dec;151(6):1123-32.

Guidelines for prescribing azathioprine in dermatology.

Anstey AV, Wakelin S, Reynolds NJ; British Association of Dermatologists Therapy, Guidelines and Audit Subcommittee.

Source

Department of Dermatology, Royal Gwent Hospital, Cardiff Road, Newport, Gwent NP20 2UB, Wales, UK. alex.anstey@gwent.wales.nhs.uk

Abstract

Azathioprine has been available as an immunosuppressive agent for over 40 years, and current routine usage in dermatology is not restricted to licensed indications. Advances in understanding the metabolic fate of azathioprine have led to significant changes in prescribing practice and toxicity monitoring by U.K. dermatologists. The current state of knowledge concerning the use of azathioprine in dermatology is summarized, with identification of strength of evidence. Clinical indications and contraindications for azathioprine usage in dermatology are identified. Evidence-based recommendations are made for routine safety monitoring of patients treated with azathioprine, including pretreatment assessment of red blood cell thiopurine methyltransferase activity.

PMID:: 15606506; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Azathioprine in dermatology: a survey of current practice in the U.K. [Br J Dermatol. 1997]
Azathioprine in dermatology: a survey of current practice in the U.K.
Tan BB, Lear JT, Gawkrodger DJ, English JS. Br J Dermatol. 1997 Mar; 136(3):351-5.
Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription. [J Clin Pharm Ther. 2007]
Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
Fargher EA, Tricker K, Newman W, Elliott R, Roberts SA, Shaffer JL, Bruce I, Payne K. J Clin Pharm Ther. 2007 Apr; 32(2):187-95.
Review Immunosuppressive agents in dermatology. An update. [Dermatol Clin. 1998]
Review Immunosuppressive agents in dermatology. An update.
Dutz JP, Ho VC. Dermatol Clin. 1998 Apr; 16(2):235-51.
Review Azathioprine: a guide for the management of dermatology patients. [Dermatol Ther. 2007]
Review Azathioprine: a guide for the management of dermatology patients.
Wise M, Callen JP. Dermatol Ther. 2007 Jul-Aug; 20(4):206-15.
Review Immunosuppressive agents in dermatology. [Dermatol Clin. 1993]
Review Immunosuppressive agents in dermatology.
Ho VC, Zloty DM. Dermatol Clin. 1993 Jan; 11(1):73-85.

See reviews... See all...

Cited by 4 PubMed Central articles

Azathioprine induced cholestatic hepatitis. [Indian J Pharmacol. 2011]
Azathioprine induced cholestatic hepatitis.
Moses V, Ramakrishna B, Thomas K. Indian J Pharmacol. 2011 Nov; 43(6):733-5.
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. [Clin Pharmacol Ther. 2011]
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.
Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui CH, Yee SW, Stein CM, Carrillo M, Evans WE, Klein TE, et al. Clin Pharmacol Ther. 2011 Mar; 89(3):387-91. Epub 2011 Jan 26.
Review Atopic and non-atopic eczema. [BMJ. 2006]
Review Atopic and non-atopic eczema.
Brown S, Reynolds NJ. BMJ. 2006 Mar 11; 332(7541):584-8.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Guidelines for prescribing azathioprine in dermatology.
Guidelines for prescribing azathioprine in dermatology.
Br J Dermatol. 2004 Dec ;151(6):1123-32.

PubMed
Intravenous CDP870, a PEGylated Fab' fragment of a humanized antitumour necrosis...
Intravenous CDP870, a PEGylated Fab' fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: an exploratory study.
Aliment Pharmacol Ther. 2004 Dec ;20(11-12):1337-46.

PubMed
Effects of short-term treatment with metformin on markers of endothelial functio...
Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
J Intern Med. 2005 Jan ;257(1):100-9.

PubMed
Probiotics and gastrointestinal diseases.
Probiotics and gastrointestinal diseases.
J Intern Med. 2005 Jan ;257(1):78-92.

PubMed
Pharmacologic treatments for acute respiratory distress syndrome and acute lung ...
Pharmacologic treatments for acute respiratory distress syndrome and acute lung injury: systematic review and meta-analysis.
Treat Respir Med. 2004 ;3(5):307-28.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Guidelines for prescribing azathioprine in dermatology.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information